Virginia Cancer Specialists' Research Director Honored with National Excellence Award
Virginia Cancer Specialists, a leading oncology practice in Northern Virginia, is thrilled to announce that Marcy Sullivan, RN, BSN, OCN, the Director of Research Operations at their Research Institute, has been honored with the prestigious Sarah Cannon Research Institute (SCRI) Site Partnership Excellence Award. This accolade recognizes exceptional leaders in research operations who demonstrate outstanding collaboration and commitment to enhancing clinical research through effective partnerships within the SCRI network.
With her extensive experience in clinical research, Marcy Sullivan's recognition illustrates her significant contributions to the field and the steadfast partnership she has fostered between Virginia Cancer Specialists and the SCRI. The SCRI is one of the foremost oncology research organizations globally, conducting clinical trials that have been instrumental in the approval of numerous cancer therapies by the FDA over the past decade. Marcy's impact at Virginia Cancer Specialists not only enhances patient access to innovative trials but also upholds the highest standards in research execution and patient care.
In her roles, Marcy has excelled in building trust and collaboration within the network, improving operational processes, and ensuring that clinical trials are conducted with the utmost quality. Karin Choquette, the AVP of Research Site Operations at SCRI, emphasized Marcy's skill in creating meaningful partnerships, stating, "Her leadership has created a lasting impact not only at Virginia Cancer Specialists but across our entire network. It is an honor to work alongside her."
Since the partnership with SCRI began in 2024, Virginia Cancer Specialists has strived to provide patients throughout Northern Virginia with access to pioneering clinical trials and advanced cancer therapies. This collaboration merges community-level oncology care with nationally recognized research expertise, bringing valuable investigational treatments closer to local patients.
Dr. Alex Spira, a medical oncologist and the Co-Director of the Virginia Cancer Specialists Research Program, praised Marcy's dedication, remarking, "Her commitment to scientific rigor and operational excellence enhances our ability to facilitate complex clinical trials. We see firsthand the positive outcomes for our patients, thanks to her leadership."
The Executive Director of Virginia Cancer Specialists, Ann Miner, shared her pride in Marcy's achievements, noting, "This award is a testament to the impact Marcy has made through her dedication to research excellence and patient care. We are honored to have her lead our research efforts."
As the largest private cancer practice in Northern Virginia, Virginia Cancer Specialists has been recognized multiple times for its excellence in cancer care. With a dedicated research facility that supports Phase I and later-stage clinical trials in collaboration with NEXT Oncology, Virginia Cancer Specialists continues pushing the boundaries of treatment options available to patients.
Through strong partnerships and a commitment to innovation, Virginia Cancer Specialists is dedicated to advancing cancer care. As they celebrate Marcy's achievements, the practice remains focused on expanding access to breakthrough therapies that can genuinely enhance patient outcomes. This recognition underlines their ongoing mission of improving cancer care quality and accessibility across the region. For more details about Virginia Cancer Specialists and their research programs, you can visit their official website.
With her extensive experience in clinical research, Marcy Sullivan's recognition illustrates her significant contributions to the field and the steadfast partnership she has fostered between Virginia Cancer Specialists and the SCRI. The SCRI is one of the foremost oncology research organizations globally, conducting clinical trials that have been instrumental in the approval of numerous cancer therapies by the FDA over the past decade. Marcy's impact at Virginia Cancer Specialists not only enhances patient access to innovative trials but also upholds the highest standards in research execution and patient care.
In her roles, Marcy has excelled in building trust and collaboration within the network, improving operational processes, and ensuring that clinical trials are conducted with the utmost quality. Karin Choquette, the AVP of Research Site Operations at SCRI, emphasized Marcy's skill in creating meaningful partnerships, stating, "Her leadership has created a lasting impact not only at Virginia Cancer Specialists but across our entire network. It is an honor to work alongside her."
Since the partnership with SCRI began in 2024, Virginia Cancer Specialists has strived to provide patients throughout Northern Virginia with access to pioneering clinical trials and advanced cancer therapies. This collaboration merges community-level oncology care with nationally recognized research expertise, bringing valuable investigational treatments closer to local patients.
Dr. Alex Spira, a medical oncologist and the Co-Director of the Virginia Cancer Specialists Research Program, praised Marcy's dedication, remarking, "Her commitment to scientific rigor and operational excellence enhances our ability to facilitate complex clinical trials. We see firsthand the positive outcomes for our patients, thanks to her leadership."
The Executive Director of Virginia Cancer Specialists, Ann Miner, shared her pride in Marcy's achievements, noting, "This award is a testament to the impact Marcy has made through her dedication to research excellence and patient care. We are honored to have her lead our research efforts."
As the largest private cancer practice in Northern Virginia, Virginia Cancer Specialists has been recognized multiple times for its excellence in cancer care. With a dedicated research facility that supports Phase I and later-stage clinical trials in collaboration with NEXT Oncology, Virginia Cancer Specialists continues pushing the boundaries of treatment options available to patients.
Through strong partnerships and a commitment to innovation, Virginia Cancer Specialists is dedicated to advancing cancer care. As they celebrate Marcy's achievements, the practice remains focused on expanding access to breakthrough therapies that can genuinely enhance patient outcomes. This recognition underlines their ongoing mission of improving cancer care quality and accessibility across the region. For more details about Virginia Cancer Specialists and their research programs, you can visit their official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.